Matches in Nanopublications for { ?s ?p "[Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP114368.RA_CCGwBttw6vJIT6CSQhE0VqYelDA-5krMel3WMXXHSM130_assertion description "[Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114368.RA_CCGwBttw6vJIT6CSQhE0VqYelDA-5krMel3WMXXHSM130_provenance.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion description "[Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.